Congratulations to Precision Vaccines Program member Dr Oludare Odumade for graduating from the Harvard Perinatal and Neonatal Fellowship! 🎉 🎓 We are so proud of you, Dare! Dr. Ofer Levy, MD PhD

Precision Vaccines Program Director Dr. Ofer Levy, MD PhD will serve on #FDA VRBPAC advisory committee tomorrow, June 5th, 2024 to discuss #COVID vaccines for the fall. The live session can be viewed here: fda.gov/advisory-commi…

Wonderful to be at tonight’s #Celtics game with my son Manu!!

#NewProfilePic

New article in Nature Portfolio’s Communications Biology led by Precision Vaccines Program researchers Simone Schüller, Soumik Barman, Dr. Ofer Levy, MD PhD & Dr. David J. Dowling, Ph.D. characterizes adjuvant-specific innate immune responses across the human lifespan. Schüller and Barman et al. 2024: nature.com/articles/s4200…

New article in Communications Biology led by Precision Vaccines Program researchers Drs Soumik Barman, Dr. Ofer Levy, MD PhD & Dr. David J. Dowling, Ph.D. characterizes adjuvant specific innate immune responses across life span using cutting-edge CyTOF technology and computational approaches. #CyTOF nature.com/articles/s4200…

Our collaborators including Dr. Ofer Levy, MD PhD Hanno Steen + others identify markers of severity for #hospitalized pts with #covid19 as part of #IMPACC project including 1117 pts. #plasma #proteomics Science Advances ncbi.nlm.nih.gov/pmc/articles/P…

As a co-founder of OVAX. I’m pleased to report our company has emerged from stealth mode #vaccines #OD. bloomberg.com/news/articles/… via Bloomberg Technology

Check out this article! A Precision Vaccines Program team led by Drs Dr. Ofer Levy, MD PhD & Dr. David J. Dowling, Ph.D. identified PVP-037, a novel small molecule #adjuvant that may enhance immunogenicity of vaccines for various diseases, including allergy, oncology, and opioid #overdose. answers.childrenshospital.org/promising-vacc…

Modeling human immune responses to vaccination in vitro. A review by Precision Vaccines Program Dr. Ofer Levy, MD PhD et al. in Trends in Immunology #ISSCR2024 hubs.li/Q02F_4430

Many thanks for the team at Nature for interviewing me for this article re the power of human in vitro modeling: Animal research is not always king: researchers should explore the alternatives nature.com/articles/d4158…

Precision Vaccines Program Director Dr. Ofer Levy, MD PhD of Boston Children's is quoted in the journal nature! He highlights human in vitro models as alternatives to animal models in preclinical research: nature.com/articles/d4158… #biotech

Published now in Science Translational Medicine! Precision Vaccines Program researchers @Biotech_Byron, Dr. Ofer Levy, MD PhD, & Dr. David J. Dowling, Ph.D. along with Romain Micol at Combined Therapeutics discover a novel adjuvant system called IL-12 MOP and highlight its importance in #mRNA vaccine technology. science.org/doi/10.1126/sc…

In a new study, Dowling and Levy expand on this concept, using mRNAs encoding a single cytokine. Kudos to the authors on this excellent study. So much more to learn as we expand beyond the antigen-only use of mRNA-LNP vaccination approaches. science.org/doi/10.1126/sc…

Our collaborators publish insights into the 1st week of life, and how #breastfeeding timing influences #immunity + neutrophils Authors include Dr. Ofer Levy, MD PhD Beate Kampmann Al Ozonoff and Tobias Kollmann. J Immunol Newborns in #Gambia and #NewGuinea included. ncbi.nlm.nih.gov/pmc/articles/P…

Today is National Fentanyl Prevention and Awareness Day. Precision Vaccines Program Director Dr. Ofer Levy, MD PhD and Dr. David J. Dowling, Ph.D. are working with the NIH on developing a vaccine against opioid overdose. #FacingFentanyl #EducateActPrevent ow.ly/xp3J50T2j5k ow.ly/x5pK50T2j5j

"Precision adjuvants for pediatric vaccines" is out in Science Translational Medicine! Congrats to Dr. Anjali Singh from NIAID News , PVP Director Dr. Ofer Levy, MD PhD , and Professor of Microbiology and Immunology at UNC, Dr. Kristina De Paris for their publication! 💉science.org/doi/10.1126/sc…

PVP Director Dr Dr. Ofer Levy, MD PhD presented on the NIAID News Immune Development in Early Life (IDEAL) U19 program today in Washington DC!

New study on 1st week of #infant #immune system from our collaborators - examines DNA #methylation signatures Dr. Ofer Levy, MD PhD Beate Kampmann Olubukola (Bukky) Idoko Hancock Lab UBC @[email protected] (and Scott Tebbutt, Tobias Kollmann, not on this platform.) Nature Communications Precision Vaccines Program ncbi.nlm.nih.gov/pmc/articles/P…

Out now in Frontiers - Immunology! Drs Kinga Smolen Dr. Ofer Levy, MD PhD @OludareOdumade and Precision Vaccines Program @EPICvaccines collaborators demonstrated that plasma ADA levels in #newborns in Papua New Guinea have significantly lower ADA levels at birth than in The Gambia but converge in early infancy.